Study of Quadrivalent Influenza Vaccine Among Children

NCT01240746 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

4363

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: Licensed 2010-2011 Trivalent Influenza Vaccine, No Preservative
BIOLOGICAL: Investigational Trivalent Influenza Vaccine with alternate B strain, No Preservative
BIOLOGICAL: Quadrivalent Influenza Vaccine, No Preservative

Sponsor

Sanofi Pasteur, a Sanofi Company